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Abstract: Background: Clinical practice evaluates cardiovascular risk based on current risk factor (RF) levels [Blood 
pressure (BP), body mass index (BMI) and glycaemic control] largely disregarding previous risk-factor history over the 
totality of the life course. RFs are related to contemporaneous echocardiographic measures of cardiac structure and 
function which in turn are independently related to cardiovascular morbidity and mortality in cross-sectional studies. 
However, the effect of lifetime or earlier RF history on future echocardiographic changes has never been systematically 
examined. 
Methods: A systematic review of the published literature identified 24 studies relating either earlier BP, BMI, glycaemic 
control or a combination to future cardiac structure and/or function. 
Results: The majority of studies showed that elevated BP and BMI in earlier life and greater cumulative burden of these 
factors resulted in worse cardiac structure up to 24 years later. Studies examining glycaemic control as a RF were few, 
but poorer glycaemic control in young adults was associated with increased future left ventricular mass. 
While only 5 papers related RFs to future cardiac function, all RFs were positively associated with worse future diastolic 
function.  
Conclusions: BP, BMI and glycaemic control measures in childhood, adolescence and early adulthood and subsequent 
longitudinal trajectories of BP and BMI are predictive of future abnormalities in cardiac structure and function. Lifetime 
RF history should be used to inform clinical practice. Further research is required to enable the identification of any 
sensitive periods in the life course to enable prevention when it is most likely to be effective.  
Keywords: Life course Cardiology, echocardiography, blood pressure, glucose, body mass index. 
INTRODUCTION 
Clinical practice is to evaluate cardiovascular risk 
based on current risk factor levels largely disregarding 
previous risk-factor history over the totality of the life 
course. This is because there is a large clear literature 
associating current risk with cardiovascular morbidity 
and mortality [1]. There is also literature cross-
sectionally associating current risk factors with 
echocardiographic changes and outcomes with these 
changes relating to cardiovascular events [2]. However, 
the effect of lifetime risk factor history on future 
echocardiographic changes has never been 
systematically examined. 
Several cardiovascular risk factors correlate with 
echocardiographic changes and outcomes in cross-
sectional studies. Elevated blood pressure (BP) and 
body mass index (BMI) have been associated cross-
sectionally with increased left ventricular mass (LVM) 
and, in some cases, with left ventricular hypertrophy 
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(LVH) [3] and both elevated LVM and LVH are 
independent predictors of cardiovascular morbidity and 
mortality [2, 4]. There has also been some research 
relating presence or absence of diabetes to later 
echocardiographic outcomes [5]. However, less is 
known about how earlier-life levels of these risk factors, 
changes in risk factors, and duration of and long-term 
control of hypertension, obesity and diabetes is 
associated with subsequent cardiac morphology and 
function [6]. 
A life course approach to epidemiology investigates 
long-term biological, behavioural and psychosocial 
processes that link adult health and disease risk to 
physical and social exposures occurring in gestation, 
childhood, adolescence, earlier in adulthood or across 
generations [7]. Such an approach acknowledges the 
importance of the established adult Coronary Heart 
Disease (CHD) risk factors to later health, but adds a 
longitudinal aspect by considering the continuity and 
tracking of these risk factors across the life course [8, 
9]. 
There is a growing appreciation that exposures to 
established CHD risk factors (e.g. elevated BP, BMI Cardiovascular Risk Factors from Early Life Predict Future Adult  Journal of Cardiology and Therapeutics, 2014, Vol. 2, No. 2      79 
and poor glycaemic control) from conception onwards 
through childhood and early adulthood can influence 
later cardiovascular morbidity and mortality and 
therefore, potentially cardiac structure and function [10, 
11]. However what remains unclear is whether 
detrimental changes in cardiac structure and function 
are caused by exposures at particularly sensitive points 
in an individual’s life, the overall cumulative burden of 
exposure, or accelerated change during particular 
phases of life. For example, it is unknown whether 
being overweight from the age of 20 years onwards is 
more detrimental to the heart at the age of 60 years, 
than first becoming overweight at the age of 50 years, 
or whether for individuals with the same current BP, the 
effect on cardiac structure and function varies 
depending on whether there had been a gradual 
increase in BP over a 30 year period or a steeper 
increase over a shorter period. 
We conducted a systematic review of the published 
literature to determine if increasing lifetime exposure to 
raised BP, BMI and impaired glycaemic control was 
associated with worse future cardiac structure and 
function. 
METHODS 
Criteria for Study Inclusion and Search Strategy 
Studies eligible for inclusion were observational 
studies with longitudinal repeated measures of one or 
more of the exposures of interest (BP, BMI and 
glycaemic control) and at least one echocardiographic 
examination of participants (looking at cardiac structure 
and/or function) in adulthood. Eligible study samples 
consisted of individuals who were healthy, non-
disabled and community-dwelling at the time of 
measurement of the risk factors, the risk factors having 
being analysed as continuous variables. 
Outcomes considered were any echocardiographic 
measures of cardiac structure (e.g. wall and chamber 
dimensions and volumes) or function (e.g. fractional 
shortening (FS), E/A ratio, and tissue Doppler based 
measures such as E/e’ ratio). 
Searches of the electronic databases PubMed and 
EMBASE (January 1966 to October 2013) were 
performed using the following Mesh terms: (longitudinal 
OR cohort OR life course OR lifecourse OR follow up 
OR tracking) AND (blood pressure measurements OR 
body mass index measurements OR birth weight OR 
lipids OR glycaemic control) AND (echocardiography). 
The detailed search strategy is outlined in the online 
supplemental material. Figure 1 summarises the 
identification of studies. There were 1096 unique 
records which were screened. A total of 24 papers 
were identified using a screening questionnaire after 
screening the full text of 36 potentially eligible papers. 
Any uncertainty about study eligibility was resolved 
through discussion between 3 of the authors. Details of 
 
Figure 1: Flow of studies through the review (after the PRISMA and MOOSE statements) [12, 13].
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relevant published results, study population, 
measurement of risk factors and outcome and details 
of statistical analysis were extracted from the papers 
using a data extraction form.  
The analyses presented in the papers were too 
varied to be able to carry out a formal meta-analysis of 
the published data. Furthermore, the cardiac outcomes 
assessed and the ages at which risk factors were 
measured were too heterogeneous to carry out an 
individual level meta-analysis. Hence, no attempts 
were made to contact authors for additional 
information. 
RESULTS 
The 24 papers meeting the inclusion criteria used 
data from 13 different cohort studies. The 
characteristics of included studies are provided in 
Table 1. The full main findings and statistical methods 
used are provided in Table S1 in the online 
supplemental material. There was more than 1 paper 
from 5 studies; Framingham (2 papers), Framingham 
Offspring (4), Bogalusa (4), Uppsala (4) and CARDIA 
(2). These papers focussed on different risk factors 
and/or outcomes and were thus all included in the 
review. The range of follow up periods in these studies 
was wide, varying from 2 years to 70 years and the 
mean age of study members at baseline varied from 7 
to 89. Most studies were conducted in adult 
participants, although 4 measured risk factors in 
children with follow up into adulthood (Bogalusa, 
Hertfordshire cohort and the studies by Johnson and 
Kumaran) [14-17]. Six studies were in men only 
(Uppsala cohort studies and in the studies by 
Ridderstrale, Vijayakumar, Jokiniitty, Strand and 
Zureik) [17-25], but the majority had male and female 
participants. Bogalusa and CARDIA had a purposely 
bi-ethnic study population, while Kumaran’s study was 
on South Asian Indians and Lin’s study on Chinese 
seniors. The others consisted of European-origin 
population cohorts. 
The longitudinal relationship between risk factors 
and future cardiac structure and function was 
investigated in a variety of ways. Some related risk 
factors at a single point in time with future cardiac 
structure [3, 15, 16, 18, 20, 22-24, 26-29] we have 
called this the “prospective approach” for the purposes 
of this review. Others, with regularly repeated 
measures of risk factors, calculated summary 
measures of the risk factors over a period of time for 
each individual, for example the area under the curve 
(AUC) or rate of change, and related those to future 
cardiac structure and function [21, 29-31]. We have 
grouped these studies into an “accumulation or change 
approach” category. 
A third approach used in the Framingham Offspring 
papers concentrated on investigating risk factors in 
relation to longitudinal changes in cardiac measures, 
rather than relating changes in risk factors to cardiac 
measures at a single time point [32-35]. 
Cardiac Structure  
Blood Pressure  
The relationship between BP and cardiac structure 
was investigated in all 13 cohorts.  
Prospective Approach 
BP measured at different times across the lifetime 
has been positively related to future left ventricular (LV) 
wall thickness and mass. 
Childhood Systolic and Diastolic BP (SBP and DBP) 
(average age 13.3 years) were positively associated 
with future LVM (4 years later) and LVH (19 years later) 
in Bogalusa but SBP was not associated with LV 
dilation 19 years later [16, 27, 29]. Similar positive 
associations between SBP and mean arterial pressure 
(MAP) and future LVM (measured 10-20 years later) 
were also seen in young adults (18-30 years in age) 
[23, 26]. 
Three studies considered the association between 
SBP at older ages and subsequent cardiac structure. In 
one study SBP and DBP at age 50 years were 
associated with an increased prevalence of LVH at age 
70 years [24] while in another DBP at age 42.1 years 
positively predicted LVM 20 years later [18]. Finally, in 
a study of elderly Chinese, only baseline pulse 
pressure (PP) was positively associated with LVH 4 
years later [28]. 
Accumulation or Change Approach 
Studies have shown a positive relationship between 
SBP change across the life course and future cardiac 
structure.  
2 studies investigated the effect of rate of change in 
SBP in children or young adolescents. Greater LVM at 
age 33 years was associated with a greater cumulative 
SBP burden over a prior 23 year period (quantified by 
AUC) [30], while greater wall thickness [(interventricular 
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Table 1:  Characteristics of Studies Included in the Systematic Review 
Paper: First 
author and year 
Study name and 
location 
Analysed sample 
size (at last 
examination 
round if not 
further qualified) 
Mean Age +/- 1SD 
(Age range)  
in years at last 
follow up (unless 
otherwise 
mentioned) 
Maximum 
duration of follow 
up in years and 
maximum number 
of repeated 
examination 
rounds for the 
purpose of quoted 
paper 
Repeat 
measure(s) 
related to 
echocardiographi
c outcome for the 
purpose of quoted 
paper (not all 
measures may 
have been taken 
in all rounds) 
Cardiac Outcome 
measure(s) 
Johnson 
1983 
Bourbon County, 
USA 
837 at baseline; 77 
men and 51 women 
qualified for final 
inclusion 
16-19 at baseline  5 and 1  BP*, BMI†  Structure and 
function 
Lauer 
1991 
Framingham, USA   451 (152 men and 
299 women) 
68 +/- 6   30 and 16  BP, BMI  Structure 
Urbina 
1995 
Bogalusa, USA  90 males and 70 
females at first 
echocardiography 
round 
13.3 at first 
echocardiography 
round 
(9-22) 
4 with 1 follow-up 
round of 
echocardiography 
BP, weight, height  Structure 
Vasan 
1995 
Framingham, USA  2803 men and 
3411 women at 
baseline; 1849 men 
and 2152 women at 
1
st follow up  
20-89 at baseline  8 and 1  BP, BMI  Structure 
Vijayakumar 
1995 
Hertfordshire  
Cohort, UK 
290 men   66.9 +/- 3.2  70 and 2  BP, BMI, glucose 
and insulin 
Structure 
Zureik 
1995 
Paris, France  177 men  51.6 +/- 2.9 
(47-58) 
2 and 1  BP, BMI  Structure 
Kumaran 
2000 
Mysore, India  435 (237 men and 
198 women) 
49.5 +/- 4.8  49.5 and 1  BP, BMI  Structure 
Arnlov 
2001 
Uppsala, Sweden  2330 at baseline, 
1227 at 1
st follow-
up (431 men 
qualified for 
inclusion) 
48-51 in the 1
st 
round 
20 and 1  Glycaemic control  Function 
Jokiniitty 
2001 
Tampere, Finland  97 men at baseline 
and 86 men at 
follow up 
35-45  10 and 1  BP, BMI  Structure 
Sundstrom 
2001 
Uppsala, Sweden  2322 men at 
baseline; 1221 at 
follow-up (475 
qualified for 
inclusion) 
70-74  20 and 1  BP, BMI, glycaemic 
control 
Structure 
Bjorklund 
2002 
Uppsala, Sweden  2322 men at 
baseline; 1221 at 
follow-up (583 
qualified for 
inclusion) 
70  20 and 1  BP  Structure and 
function 
Gardin 
2002 
CARDIA, USA  5115 at baseline; 
4243 at 1
st follow-
up; 1536 at 2
nd 
follow-up; 1189 
qualified for 
inclusion (544 men 
and 645 women) 
18-30 at baseline  10 and 2  BP, BMI  Structure 
Lorber 
2003 
CARDIA, USA  737 men and 881 
women 
18-30 at baseline  10 and 5  BP, BMI, fasting 
insulin levels 
Structure 
Li  
2004 
Bogalusa, USA  1420 at baseline; 
467 at 6
th follow-up 
(182 men and 285 
women) 
32.6  
(20-38) 
 
23 and 2 to 12 
follow-ups with an 
average of 6 
BP, BMI  Structure 
Arnlov 
2005 
Uppsala, Sweden  2330 at baseline; 
1227 at follow-up 
(505 men qualified 
for inclusion) 
70  20 and 1  BP, BMI, glycaemic 
control 
Structure and 
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(Table 1). Continued. 
Paper: First 
author and year 
Study name and 
location 
Analysed sample 
size (at last 
examination 
round if not 
further qualified) 
Mean Age +/- 1SD 
(Age range)  
in years at last 
follow up (unless 
otherwise 
mentioned) 
Maximum 
duration of follow 
up in years and 
maximum number 
of repeated 
examination 
rounds for the 
purpose of quoted 
paper 
Repeat 
measure(s) 
related to 
echocardiographi
c outcome for the 
purpose of quoted 
paper (not all 
measures may 
have been taken 
in all rounds) 
Cardiac Outcome 
measure(s) 
Haji 
2006 
Bogalusa, USA  197 men and 309 
women 
32 +/- 3  23 and 2 to 12 
follow-ups with an 
average of 6 
BP, BMI, fasting 
glucose  
Structure and 
function 
Strand 
2006 
Oslo, Norway  56 men  42.1 +/- 0.5 at 
baseline 
20 and 1  BP, BMI  Structure and 
function  
Lin 
2007 
The Longitudinal 
Study of Aging, 
China 
193 at baseline; 
170 at 1
st follow-up; 
144 at 2
nd follow-up 
(81 men and 24 
women qualified for 
inclusion) 
71.7 +/- 3.9 
(60-81) 
4 and 2  BP, BMI, glycaemic 
control 
Structure and 
function 
Toprak 
2008 
Bogalusa, USA  338 men and 486 
women 
36 
(24-44) 
24 and 1  BP, BMI, glucose  Structure 
Lieb 
2009 
Framingham 
Offspring, USA 
1973 men and 
2244 women in 
long term study; 
1094 men and 
1511 women in 
short term study 
45   4 to 16 and 
maximum of 4 
follow-ups 
BP, BMI, diabetic 
status 
Structure 
Cheng 
2010 
Framingham 
Offspring, USA 
1851 men and 
2211 women 
45 +/- 10 at 
baseline 
 16 and 4  BP, BMI, fasting 
glucose 
Structure and 
function 
Lam 
2010 
Framingham 
Offspring, USA 
1671 men and 
1835 women in 
short term group; 
2187 men and 
2355 women in 
long term group 
52+/-10 for men 
and 51+/-10 for 
women in short 
term group; 46+/-10 
for men and 45+/-
10 for women in 
long term group 
(25-74) 
4 to 16 and 2-6 
follow-ups 
BP, BMI  Structure 
McManus 
2010 
Framingham 
Offspring, USA 
2102 men and 
2301 women in 
long term group; 
1559 men and 
1806 women in 
short term group 
45  4 to 16 and 
maximum of 4 
follow-ups 
BP, BMI, diabetic 
status 
Structure 
Ridderstrale 
2010 
Military recruits, 
Sweden 
74 male army 
recruits at baseline, 
64 at follow-up 
40  20 and 1  BP, BMI,   Structure and 
function 
*Blood Pressure † Body Mass Index.  
wall thickness (LVPWT)] but not left ventricular internal 
diameter (LVID) in 21 to 24 year olds was associated 
with sustained higher BP over the preceding 5 years 
[14]. 
In young black men and black women a greater 
increase in SBP over 10 years was positively 
associated with future LVM index (LVMI) [31]. 
Similar relationships between sustained 
hypertension or increased SBP and future wall 
thickness were also seen in older individuals - in 
Uppsala (50 y at baseline, 20 y follow up) [21] and in a 
Parisian cohort (47-58y at baseline, 2y follow up) [25]. 
BMI and Weight 
Prospective Approach 
Greater BMI has been associated with greater 
future LVM, however this relationship is more complex 
when very early BMI or weight is considered.  
The relationship between weight at birth or in 
infancy with later cardiac structure has been 
investigated in 2 studies.  
Birth weight was not associated with LVMI or left 
ventricular geometry (LVG) at a mean age of 49.5 
years, and a longer length at birth showed a weak and 
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and relative wall thickness (RWT) [15]. However in the 
study with the longest follow-up, greater weight at 1 
year was associated with lower LVM, IVSD, LVPWT 
and RWT, but was not associated with LVID at a mean 
age of 70 years [17]. 
When baseline BMI or weight in children and young 
adolescents was positively related to future cardiac 
structure, it was found to be associated with future LVM 
[29], LV dilation, eccentric LVH and left atrial diameter 
(4 years later) [16, 27]. BMI in young adults was also 
positively associated with LVM 10 or 20 years later [23, 
26. 
BMI was also related to future cardiac structure in 2 
older cohorts where it was predictive of future LVMI 
after 4 or 10 years (baseline ages 35-45 and 71.7 
years) [22, 28]. High BMI at the age of 50 years was 
also associated with increased prevalence of LVH and 
higher left atrial diameter at 70 years [20, 24]. 
Risk Factor Accumulation or Change Approach 
Relating increases in BMI to future LV structure has 
only been carried out in young and older adults. A 
greater cumulative BMI burden (AUC) over a period of 
23 years was associated with a higher LVM at 33 years 
[30]. Among black men and black and white women, 
greater increases in BMI over a 10 year period, were 
associated with a greater LVMI at ages 28-40 years 
[26]. 
In older individuals (52y old men) BMI changes 
were not associated with changes in LV structure. 
However follow up here was only for 2 years [25]. 
Glycaemic Control 
Although no relationships were found between 
childhood glycaemic control and later cardiac structure, 
this was not the case for later measures of glycaemia. 
Only 4 studies have looked at the prospective effect 
of glycaemic control on cardiac structure [16, 20, 23, 
28]. 
In children, fasting glucose was not associated with 
LVH 24 years later [16]. However in 20 year olds, 
baseline insulin was associated with LVMI measured 
20 years subsequently.  
Relationships between glycaemic control and 
cardiac structure were evident in older cohorts. 
Proinsulin levels at age 50 years were positively 
correlated with left atrial diameter at age 70 years [20], 
while fasting glucose at baseline was positively 
correlated with year 4 LVMI in Chinese seniors [28]. 
Longitudinal Modelling of Cardiac Outcomes 
Instead of modelling changes in risk factors, the 
Framingham Offspring Study papers have concen-
trated on relating risk factors to longitudinal changes in 
cardiac measures over 16 year and 4 year periods [32-
35]. 
Higher SBP was associated with higher LVMI, and 
higher SBP and PP were significantly related to greater 
LV dimensions and wall thickness as well as larger left 
atrial diameter [34]. The relationships between BP and 
change in aortic root diameter were more complex with 
lower SBP and PP and higher DBP and MAP being 
associated with higher follow-up aortic root diameter 
[35]. 
BMI was also related to changes in cardiac 
structure with positive associations with LVID, LV wall 
thickness [32] and LVM, the last association being 
stronger in women [34]. Higher BMI was also positively 
associated with greater aortic root diameter [33]. 
Cardiac Function 
Although the number of studies investigating the 
effect of risk factors on future cardiac function was 
limited, BP, BMI and glycaemic control were all 
predictors of future cardiac function. 
A total of 9 studies investigated cardiac function of 
which 4 were excluded from this section as analyses 
were carried out in a cross-sectional manner or only on 
a subgroup of the study cohort [18, 23, 27, 28]. Of the 5 
papers investigating longitudinal associations, 3 were 
on the Uppsala cohort [14, 19-21, 32]. 
Sustained higher SBP over a 5 year period in 
adolescents and young adults was positively asso-
ciated with fractional shortening (FS) and mean velocity 
of circumferential fibre shortening, measured at ages 
21-24 years [14]. In the Framingham Offspring cohort, 
SBP was positively associated with changes in FS [32]. 
In older individuals, although BP was not shown to 
have a relationship with ejection fraction (EF), higher 
SBP and DBP at age 50 years were associated with 
decreased E/A ratio and higher SBP to higher A-wave 
[20, 21]. 
BMI and glycaemic control were only considered in 
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associated with diastolic dysfunction manifest as 
decreased E/A ratio and larger A-wave after 
adjustment at age 70 [20]. Fasting glucose at 50 years 
was negatively related to EF at age 70, and positively 
correlated with E-wave [19], and specific insulin and 
proinsulin levels were positively correlated with the 
magnitude of the A-wave [20]. 
DISCUSSION 
Most studies included in the review show 
associations between higher SBP and BMI at an earlier 
time-point and poorer cardiac structure measured up to 
70 years later. Single measures of SBP and BMI 
measured in childhood, adolescence and early 
adulthood and greater cumulative burden of these risk 
factors predict cardiac measures (LVM, LV wall 
thickness) in adulthood in the few studies that look at 
this. There is a lack of studies relating birth weight, 
infant weight or glycaemic control to cardiac structure 
and a lack of studies considering the longitudinal 
relationship of any risk factor with cardiac function. 
Assessment of Bias and Justification for 
Exclusions 
Due to the variation in cardiac measures 
investigated, the variation in age at measurement of 
risk factors and length of follow-up, and the differences 
in statistical analysis with different levels of adjustment 
for potential confounding variables, it was not possible 
to perform a meta-analysis of results. We were thus 
unable to formally assess publication bias. By 
systematically reviewing the literature according to 
published guidelines and following a pre-specified 
protocol, we believe we have included all published 
results of the main associations of interest. However, 
we did limit our search to two electronic databases and 
to studies written in English and therefore may have 
missed some relevant studies. 
Interpretation of the Findings  
Ideally, life course studies require risk factors to be 
collected over a substantial period of time and at 
various phases of the life course. The few studies that 
have shown single risk factor measurements in 
childhood, adolescence or early adulthood to be 
correlated with adult echocardiographic measures may 
reflect “tracking” of the risk factor from childhood to 
adulthood [36]. Few studies investigate this possibility 
and so it remains unclear whether these observations 
can be interpreted as showing a distinct contribution 
from earlier exposure to risk factors. Current SBP 
seemed to account for the effect of SBP measured 8 
years earlier in the only study that investigated whether 
prior SBP had a predictive value independent of current 
SBP [37]. Due to the availability of only a single related 
study, whether SBP measured earlier in the life course, 
especially in childhood, adolescence or early 
adulthood, may demonstrate an independent role (by 
affecting change in a particularly sensitive period) 
remains unclear.  
Other studies suggest a “cumulative” effect of 
exposure to obesity and hypertension on later 
echocardiographic results (possibly through an accrual 
of damage over time worsened by prolonged 
exposure). However, no study has analysed the impact 
of risk factor trajectories starting from birth and 
continuing on into early, mid and later adulthood on 
cardiac structure and function at an older age. Neither 
of the two studies investigating very early weight and 
adult LVM found evidence of an association, 
suggesting that fetal development associated with low 
birth weight in the normal range exerts minimal effect 
on future LVH. However, both studies were quite small 
and may have lacked the required statistical power to 
detect a relatively small relationship.  
While this review focuses on the longitudinal effect 
of BP, BMI and glycaemic control on cardiac structure 
and function, the possibility of reverse causality cannot 
be ruled out. Some studies have explored the effects of 
an echocardiographic diagnosis (e.g. LVH) on 
subsequent levels of BP. These studies have shown 
that increased LVM, in normotensive individuals or 
subjects with optimally controlled blood pressure, 
predicts the development of future hypertension [38, 
39]. Poorer cardiac function in the form of higher EF 
has also been found to be associated with higher 
subsequent SBP [40]. 
Some studies suggest that 24 hour PP, as opposed 
to SBP, is more predictive of later LVM [22]. Different 
BP parameters (SBP, DBP, PP, MAP) reflect the effect 
of BP in subtly different ways. For example, PP de-
pends on stroke volume and arterial stiffness whereas 
MAP is determined by cardiac output and peripheral 
resistance [41, 42]. From the papers reviewed, it is not 
possible to determine which measures are most useful 
as predictors over the longer term, as different 
measures have not been compared against each other. 
Consideration of these multiple BP measurements in 
future longitudinal studies may result in better insights 
into the hemodynamic mechanisms acting over the life 
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The studies in our review showed associations 
between poorer glycaemic control and worse left 
ventricular mass, ejection fraction and E/A ratio [16, 20, 
23, 28]. However caution would be needed before 
extrapolating these findings to all population groups 
due to the small number of studies. In addition, the 
effect of long-term glycaemic control was not measured 
and although attempts were made to account for the 
role of confounding factors, it is difficult to tease out the 
effect of glycaemia independent of its effect through 
BMI.  
Implications of the Findings 
One of our striking findings was the lack of a 
standardised approach to analysis. The papers in this 
review were published between 1983 and 2010, and 
the analytical approaches have developed in line with 
the changing nature of the hypotheses with regard to 
biological mechanisms. Multivariable linear regression, 
relating the risk factor at a single time point to a 
subsequent echocardiographic measure, has been 
used in most studies. However, analyses become more 
complex if the aim is to use repeated measures of the 
risk factor. A few studies have attempted to deal with 
problems of modelling correlated measures of 
exposure by creating a summary measure for each 
individual e.g. AUC, or rate of change [43], and relating 
these to the outcome [44]. However, no studies have 
as yet attempted to disentangle the effect of 
“cumulative” risk factor burden from exposures during 
sensitive periods [45, 46]. Ultimately, there is no 
standard statistical approach to analysis linking a 
repeated exposure to a subsequent health outcome, 
and the most appropriate method will depend on the 
specific hypothesis under study and hence the plurality 
of techniques used in the included papers [47]. 
Another issue is the added complexity when 
children are followed up into early adulthood as 
childhood growth may not be adequately captured by 
changes in childhood BMI [48]. Fat mass and lean 
mass may need to be considered separately when 
analysing cardiac growth in children, but most studies 
only have measures of BMI and are thus not able to 
consider this [49, 50]. 
We also found a lack of studies dealing with the 
longitudinal effects of risk factors on cardiac function, 
and the few that have, investigate different aspects of 
systolic or diastolic function. Many of the populations 
included in the review have been young adults and as 
such, the vast majority of study subjects have had 
normal cardiac function. As a result, it is not possible to 
make a generalised systematic assessment of the 
findings and this area would benefit from further 
research. 
Some findings have also been different among 
blacks and whites in the bi-ethnic studies. Further 
research with more heterogeneous study populations 
would be helpful in making findings more generalizable.  
New research on the long-term effect of exposure to 
poorly controlled BP, BMI and glycaemia is warranted 
to better understand the mechanisms by which they 
independently, cumulatively or interactively affect later 
cardiac function and structure. The life course 
approach could help identify periods where exposures 
to risk factors may be particularly detrimental to cardiac 
function and structure. This new knowledge would be 
invaluable to inform policy related to cardiovascular 
disease prevention, enabling earlier targeted 
intervention to individuals at risk.  
CONCLUSIONS 
This systematic review provides some evidence that 
earlier elevated BP, high BMI and poor glycaemic 
control result in worse cardiac structure and function up 
to 24 years later. This information should be used to 
inform clinical practice, but it should be remembered 
the number of studies on which this evidence is based 
is limited, and the findings are difficult to generalize to 
all population groups. There is a lack of studies 
investigating either the effect of changes in risk factors 
over the life course or the cumulative effect of exposure 
to risk factors on cardiac structure and function. Future 
studies utilizing a life course approach, to identify if 
there are sensitive periods where exposure is 
particularly detrimental, might suggest time-points 
when prevention may be best targeted. Ultimately such 
information would be invaluable from a public health 
and preventive Cardiology perspective.  
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